Oct 8, 2026 06:16AM
Jul 24, 2026 06:09AM
May 21, 2026 05:51PM
Mar 16, 2026 04:07PM
Nov 10, 2025 04:05PM
Sep 11, 2025 08:18AM
Aug 22, 2025 07:47AM UBS Reiterates Buy Rating on Perspective Therapeutics Inc (CATX)
Aug 13, 2025 06:45AM
May 13, 2025 04:56AM
May 12, 2025 04:36PM
Mar 26, 2025 04:10PM
Nov 23, 2024 09:58AM
Nov 15, 2024 04:08PM
Nov 12, 2024 04:05PM Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results
Oct 10, 2024 05:14PM
Aug 16, 2024 06:26AM
Aug 12, 2024 04:05PM
May 20, 2024 07:00AM
May 15, 2024 07:00AM
May 9, 2024 06:07AM
Apr 30, 2024 07:04AM Perspective Therapeutics (CATX) Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETs
Apr 30, 2024 07:00AM
Apr 8, 2024 08:00AM
Mar 28, 2024 07:30AM
Feb 1, 2024 08:00AM
Jan 9, 2024 08:07AM
Nov 14, 2023 04:25PM
Aug 30, 2023 08:17AM Perspective Therapeutics to Present at the World Molecular Imaging Congress 2023
Aug 11, 2023 08:00AM
May 15, 2023 08:22PM
Mar 14, 2023 08:18AM
Mar 14, 2023 08:17AM

334,268 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All